European Leukemia Trial Registry
Trial: CAR.CD19 for lymphoid disease

More Details
Title Phase I/II-Studie zur Behandlung mit durch viral transduzierte T-Lymphozyten bei Patienten mit CD19 positiver lymphoider Erkrankung
Scientific Title Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector – a unicenter phase I/II clinical trial
Short Title CAR.CD19 for lymphoid disease
Trialgroup NN
Type of Trial mehrarmig, prospective, open-label, monocentic
Disease Acute lymphoblastic leukemia(ALL) B-Precursor ALL
Age All ages
Status Active
Start of Recruitment 07.09.2018
Leader Schmitt, Prof. Dr. med., Michael
Shortprotocol Shortprotocol
created 29.04.2019 Student Studienregister
changed 20.08.2020 Zenawit Krüger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org